Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 9, No 6 (2013) COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY Abstract  similar documents
I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko
"... with perindopril (groups 1 and 3, respectively) or carvedilol (groups 2 and 4, respectively). Follow-up was 6 ..."
 
Vol 7, No 3 (2011) COMPARATIVE ANALYSIS OF ARTERIAL HYPERTENSION TREATMENT IN MEN AND WOMEN BASED ON THE RESULTS OF ACCORD STUDY (ACRIDILOLE IN COMBINATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY OR TYPE 2 DIABETES) Abstract  similar documents
S. A. Shalnova, S. Yu. Martsevich, A. D. Deev, Yu. V. Lukina, E. N. Hoseva
"... Aim. To compare the efficacy and safety of carvedilol in men and women with mild to moderate ..."
 
Vol 4, No 2 (2008) BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL Abstract  similar documents
A. N. Zakirova, F. S. Zarudij, B. N. Garifullin
"... drug properties (water repellency, dipole moment, molecular mass). Trail results on carvedilol ..."
 
Vol 2, No 3 (2006) HEMODYNAMIC EFFECTS OF CARVEDILOL IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
L. I. Markova, A. I. Radzevich
"... Aim. To evaluate the influence of carvedilol (Talliton, Egis, Hungary) on daily profile of blood ..."
 
Vol 6, No 4 (2010) PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY) Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, A. D. Deev, S. A. Shalnova, R. G. Oganov
"... on carvedilol or metoprolol in patients with arterial hypertension (HT) 1-2 degrees and overweight/obesity ..."
 
Vol 5, No 3 (2009) COMPARATIVE CONTROLLED STUDY OF ANTIHYPERTENSIVE EFFICACY AND SAFETY OF CARVEDILOL IN PATIENTS WITH HYPERTENSION AND OBESITY OR DIABETES 2 TYPE (BASED ON RESULTS OF MULTICENTER TRIAL ACCORD) Abstract  similar documents
Yu. V. Yu.V. Lukina, S. Yu. Martsevich, A. D. Deev, S. A. Shalnova
"... and 11 mm Hg respectively. Angina attacks were registered less often in patients of carvedilol group (р=0,001 ..."
 
Vol 4, No 3 (2008) HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA Abstract  similar documents
A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova
"... Aim. To evaluate an influence of carvedilol on risk of hypoglycemia in patients with diabetes type ..."
 
Vol 5, No 4 (2009) METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER Abstract  similar documents
B. N. Garifullin, A. N. Zakirova, F. S. Zarudij
"... of metoprolol tartrate and carvedilol on MI pathogenesis are presented. Possible indications and treatment ..."
 
Vol 5, No 2 (2009) COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich
"... ,26±0,10kg/m2 (рem0,01/em) in metoprolol group. emCarvedilol/em in comparison with metoprolol had more positive ..."
 
Vol 6, No 4 (2010) HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD Abstract  PDF (Eng)  similar documents
A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov
"... ) received combined therapy with ramipril, emcarvedilol/em and trimetazidine. HRV parameters (derived from ECG 5 ..."
 
Vol 5, No 1 (2009) COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina
"... Aim. To evaluate antihypertensive and metabolic effects of the therapy based on emcarvedilol/em (C ..."
 
Vol 4, No 2 (2008) COMPARISON OF CARVEDILOL AND BISOPROLOL EFFICACY IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES TYPES 2 AFTER MYOCARDIAL INFARCTION Abstract  similar documents
M. E. Statsenko, S. V. Belenkova, O. E. Sporova, D. A. Ivanova, E. D. Evtereva
"... Aim. To compare efficacy of emcarvedilol/em and bisoprolol in patients with chronic heart failure (CHF ..."
 
Vol 3, No 4 (2007) EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE Abstract  similar documents
A. N. Zakirova, N. E. Zakirova, I. M. Karamova, N. Kh. Khafizov, O. V. Rasskazova
"... . They were randomized in two groups. The first group was presented with 43 patients receiving emcarvedilol/em ..."
 
Vol 8, No 4 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... Aim. To compare antihypertensive and metabolic effects of long-term treatment with emcarvedilol/em ..."
 
Vol 13, No 3 (2017) BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL Abstract  similar documents
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov
"... The review presented the importance of emcarvedilol/em using in terms of renoprotection in renal ..."
 
Vol 8, No 5 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpigina
"... (EF) of long-term treatment with emcarvedilol/em or bisoprolol in patients with arterial hypertension (HT ..."
 
Vol 1, No 3 (2005) CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL Abstract  similar documents
M. A. Statsenko, I. A. Sporova, S. V. Belenkova, N. N. Shilina
"... . The average daily doses were 5,7+0,8 mg for and 32,6+3,4 mg for emcarvedilol/em. The duration of the observation ..."
 
Vol 5, No 5 (2009) EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES Abstract  similar documents
O. V. Fedorishina, A. A. Dzizinsky, K. V. Protasov, V. A. Protasova, T. I. Kucherova, E. G. Zakharova, D. D. Baskhaeva, T. S. Sukhoroslova, O. V. Perkova
"... Aim. To evaluate a short-term efficacy and safety of nebivolol and emcarvedilol/em in hypertensive ..."
 
Vol 5, No 3 (2009) EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS Abstract  similar documents
A. R. Kiselev, V. I. Gridnev, A. S. Karavaev, O. M. Posnenkova, V. A. Shvarts, V. I. Ponomarenko, M. D. Prokhorov, B. P. Bezruchko
"... Aim. To study effects of emcarvedilol/em and metoprolol on vegetative regulation of heart ..."
 
Vol 13, No 6 (2017) THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
A. N. Zakirova, B. N. Garifullin, N. E. Zakirova
"... in experimental data. emCarvedilol/em is a third-generation beta-blocker with additional pleiotropic and antioxidant ..."
 
Vol 4, No 5 (2008) CAMELLIA TRIAL: COMPARISON IN THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... for comparable study of efficacy and safety of therapies based on β-blockers (emcarvedilol/em and metoprolol ..."
 
Vol 6, No 3 (2010) ANTIHYPERTENSIVE AND ANTIOXIDATIVE EFFECTS OF CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT/OBESITY Abstract  similar documents
V. A. Nevzorova, E. S. Potapova, O. V. Nastradin
"... Aim. To evaluate an efficacy of the 24-week antihypertensive therapy based on the emcarvedilol/em ..."
 
Vol 9, No 5 (2013) THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL Abstract  similar documents
A. I. Malyhina, M. V. Zhuravleva, A. K. Starodubtsev, M. L. Maksimov, O. A. Rogacheva
"... Aim. To evaluate the therapeutic equivalence between generic emperindopril/em (Parnavel, LLC Ozone ..."
 
Vol 7, No 4 (2011) PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY Abstract  similar documents
O. V. Dralova, M. L. Maksimov
"... problems in modern cardiology and nephrology. emPerindopril/em therapy reduces cardiovascular risk in patients ..."
 
Vol 6, No 2 (2010) EFFECTS OF CARVEDILOL ON PLATELET AGGREGATION IN MEN WITH ST-ELEVATION ACUTE MYOCARDIAL INFARCTION Abstract  PDF (Eng)  similar documents
A. N. Zakirova, B. N. Garifullin, F. S. Zarudij, N. E. Zakirova
"... Aim. To study influence of beta-blockers emcarvedilol/em and metoprolol tartrate on platelet ..."
 
Vol 4, No 3 (2008) ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES Abstract  similar documents
E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich
"... ) and of generic (VedicardolR, ≪Synthesis≫, Russia) emcarvedilols/em with estimation of their serum level. And to study ..."
 
Vol 6, No 4 (2010) COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER THE STROKE Abstract  similar documents
O. A. Ageenkova, V. A. Milyagin, N. Yu. Hozyainova
"... Aim. To evaluate influence of the combined therapy with ACE inhibitor (emperindopril/em), diuretic ..."
 
Vol 6, No 2 (2010) COMPARISON OF ENALAPRIL AND PERINDOPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND LEFT VENTRICLE SYSTOLIC DYSFUNCTION Abstract  similar documents
Yu. I. Grinshtein, O. L. Barbarash, D. A. Yakhontov, A. E. Popelysheva, V. V. Shabalin, N. B. Osetrova
"... Aim. To compare efficacy of enalapril and emperindopril/em in patients with arterial hypertension (HT ..."
 
Vol 5, No 6 (2009) RESULTS OF THE CAMELLIA TRAIL: IMPLEMENTATION IN A PRIMARY HEALTH CARE Abstract  similar documents
G. I. Nechaeva, E. N. Loginova
"... Aim. To compare the antihypertensive and metabolic effects of combined therapy (emcarvedilol/em ..."
 
Vol 10, No 2 (2014) CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part II (Treatment) Abstract  similar documents
O. V. Blagova, A. V. Nedostup, E. A. Kogan, V. A. Sulimov, Yu. V. Osipova, V. P. Sedov, A. G. Kupriyanova, V. A. Zaydenov, A. E. Donnikov, V. V. Kadochnikova
"... и лечению «идиопатических» аритмий (ИА) и синдрома дилатационной кардиомиопатии (emДКМП/em). Материал и ..."
 
Vol 10, No 1 (2014) CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part I (Diagnostics) Abstract  similar documents
O. V. Blagova, A. V. Nedostup, E. A. Kogan, V. A. Sulimov, Yu. V. Osipova, V. P. Sedov, A. G. Kupriyanova, V. A. Zaydenov, A. E. Donnikov, V. V. Kadochnikova
"... лечению «идиопатических» аритмий (ИА) и синдрома дилатационной кардиомиопатии (emДКМП/em). Материал  и методы ..."
 
Vol 7, No 3 (2011) COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM IN PATIENTS WITH ARTERIAL HYPERTENSION AND STENOTIC CORONARY ATHEROSCLEROSIS BEFORE REVASCULARIZATION: AN OPEN RANDOMIZED COMPARATIVE STUDY Abstract  similar documents
O. A. Osipova, N. N. Kurbakov, A. G. Ovsyannikov, M. A. Vlasenko
"... Aim. To compare effects of emperindopril/em and losartan potassium on the parameters of the ambulatory ..."
 
Vol 7, No 1 (2011) SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina
"... , emperindopril/em, ramipril, trandolapril. Rational Pharmacother. Card. 2011;7(1):70-74 *Автор, ответственный за ..."
 
Vol 3, No 1 (2007) RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY Abstract  similar documents
M. L. Maximov
"... of metoprolol, bisoprolol and emcarvedilol/em had been proven in CHF therapy. Nebivolol was effective in elderly ..."
 
Vol 12, No 5 (2016) Lung Function Parameters in Patients with Dilated Cardiomyopathy Complicated by Pulmonary Hypertension Abstract  similar documents
T. A. Abdullaev, Ya. R. Ahmatov, B. U. Mardanov, R. Sh. Bekbulatova
"... внешнего дыхания у больных дилатационной кардиомиопатией (emДКМП/em) с легочной гипертензией (ЛГ) и без нее ..."
 
Vol 6, No 6 (2010) HEART REMODELING AT DIFFERENT STAGES OF CHRONIC HEART FAILURE IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND DILATED CARDIOMYOPATHY Abstract  similar documents
V. V. Mazur, A. M. Kalinkin, E. S. Mazur
"... .28 and 8.94±0.15 cm) was significantly more than this in healthy volunteers (6.36±0.16, all pem0.01/em). ESS ..."
 
Vol 3, No 4 (2007) RESULTS AND COMMENTS ON ADVANCE STUDY Abstract  similar documents
S. R. Gilyarevsky
"... ). Источник: ADVANCE Collaborative Group. Effects of a fixed combination of emperindopril/em and indapamide  on ..."
 
Vol 13, No 4 (2017) USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA Abstract  similar documents
O. M. Drapkina, A. S. Lishuta
"... emperindopril/em,rosuvastatin and fixed-dose combination of emperindopril/em and indapamide, in ambulatory patients ..."
 
Vol 7, No 2 (2011) EFFECTS OF N-3 POLYUNSATURATED FATTY ACIDS ON LEFT VENTRICULAR FUNCTION AND FUNCTIONAL CAPACITY IN PATIENTS WITH DILATED CARDIOMYOPATHY Abstract  similar documents
S. Nodari, M. Triggiani, U. Campia, A. Manerba, G. Milesi, B. M. Cesana, M. Gheorghiade, L. Dei Cas
"... дилатационной кардиомиопатией (emДКМП/em). Материал и методы. В проспективное исследование были включены 133 больных ..."
 
Vol 8, No 3 (2012) EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva
"... therapy with valsartan (n=20), 80–160 mg/day , or emperindopril/em (n=21), 5–10 mg/day , in combination ..."
 
Vol 7, No 3 (2011) STROKE PREVENTION IN INTERNIST PRACTICE Abstract  similar documents
D. A. Napalkov, A. V. Zhilenko
"... adjusting individual treatment depending on clinical conditions. The composition of emperindopril/em ..."
 
Vol 13, No 2 (2017) COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH Abstract  similar documents
O. M. Drapkina
"... with emperindopril/em (as monotherapy or as a fixed combination with amlodipine or indapamide) together with lipid ..."
 
Vol 13, No 3 (2017) TREATMENT OF ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN REAL CLINICAL PRACTICE. THE SYNERGY STUDY. Part 2 Abstract  similar documents
O. M. Drapkina, A. S. Luishuta
"... Aim. To study the antihypertensive and hypolipidemic effect of therapy based on emperindopril/em ..."
 
Vol 15, No 2 (2019) Modern Recommendations and Real Clinical Practice: the Results of the SILA Study Abstract  similar documents
O. A. Kislyak, I. I. Chukaeva, V. A. Vygodin
"... Aim. To assess efficacy and safety of single-pill combination (SPC) amlodipine/emperindopril/em ..."
 
Vol 15, No 6 (2019) Russian Trial ALGORITHM: Implementation of Combined Antihypertensive and Hypolipidemic Treatment for Clinical Efficacy Achievement in Routine Clinical Practice Abstract  similar documents
D. A. Napalkov
"... of antihypertensive and hypolipidemic therapy with fixed combinations of indapamide/emperindopril/em, amlodipine ..."
 
Vol 2, No 2 (2006) THE INFLUENCE OF LONG-TERM THERAPY WITH PERINDOPRIL ON THE HEART INOTROPIC FUNCTION IN PATIENTS WITH CHRONIC POSTINFARCTION ANEURISM Abstract  similar documents
I. G. Fomina, N. A. Galanina, Z. O. Georgadze, N. E. Gaidamakina
"... Aim. To study the influence of long-term therapy with emperindopril/em on the heart inotropic function ..."
 
Vol 4, No 2 (2008) ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION Abstract  similar documents
M. P. Metrova, A. B. Salmina, A. I. Inzhutova, O. S. Bahmeteva
"... Aim. To study effects of ACE inhibitor emperindopril/em on markers of endothelial dysfunction ..."
 
Vol 5, No 4 (2009) THE CAMELLIA TRIAL: SCIENTIFIC VALUE AND RECOMMENDS FOR PRACTITIONER Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, S. A. Shalnova, R. G. Oganov
"... emкарведилоле/em и метопрололе. ..."
 
Vol 7, No 6 (2011) EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS Abstract  similar documents
V. E. Oleynikov, I. B. Matrosova, Y. A. Tomashevskaya, L. I. Gusakovskaya, E. A. Melnikova
"... Hg; p0.em001/em; dyastolic BP decreased from 90 (87;93) to 80 (77;84) mm Hg; p0.em001/em ..."
 
Vol 5, No 6 (2009) ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE Abstract  similar documents
E. A. Ryabikhin, M. E. Mozheiko
"... Aim. To compare the antihypertensive and metabolic effects of combined therapy (emcarvedilol/em ..."
 
Vol 8, No 5 (2012) ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE Abstract  similar documents
M. V. Surovtseva, N. A. Koziolova, A. I. Chernyavina
"... on received drugs: emperindopril/em and ivabradine - group 1; emperindopril/em, bisoprolol and ivabradine - group 2 ..."
 
Vol 6, No 5 (2010) WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT? Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov
"... ) — emcarvedilol/em, group 3 (n=30) — nebivolol. Study duration was 6 months. Clinical examination (physical ..."
 
Vol 6, No 4 (2010) ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? Abstract  similar documents
D. V. Nebieridze, A. S. Safarian
"... . However this property can not be extended to all ACE inhibitors. Only ramipril and emperindopril/em have ..."
 
Vol 10, No 2 (2014) RESIDENT PROGENITOR CARDIAC CELLS IN PATIENTS WITH DILATED CARDIOMYOPATHY AND CONGESTIVE HEART FAILURE Abstract  similar documents
T. G. Kulikova, O. V. Stepanova, M. P. Valihov, A. Yu. Shhedrina, A. N. Samko, V. P. Masenko, S. N. Tereshhenko
"... клинические характеристики пациентов с дилатационной кардиомиопатией  (emДКМП/em) и хронической сердечной ..."
 
Vol 7, No 2 (2011) SUDDEN CARDIAC DEATH: PROBLEM OF RISK STRATIFICATION AND CHOICE OF THERAPY Abstract  similar documents
E. V. Filippov, S. S. Yakushin
"... emДКМП/em и дисфункцией ЛЖ (ФВ35%) и ХСН II-III ФК по NYHA В ИКД показана пациентам с дисфункцией ЛЖ (ФВ ..."
 
Vol 7, No 2 (2011) COMMENTS TO THE PAPER S. NODARI ET AL. «EFFECTS OF N-3 POLYUNSATURATED FATTY ACIDS ON LEFT VENTRICULAR FUNCTION AND FUNCTIONAL CAPACITY IN PATIENTS WITH DILATED CARDIOMYOPATHY»  similar documents
S. N. Tereshchenko
"... Рациональная Фармакотерапия в Кардиологии 2011;7(2) 257 Дилатационные кардиомиопатии (emДКМП/em) являют ..."
 
Vol 7, No 3 (2011) EFFECT OF THERAPEUTIC TRAINING AND ACTIVE OUTPATIENT MANAGEMENT ON CLINICAL STATE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE (THREE YEAR FOLLOW-UP) Abstract  similar documents
A. P. Rebrov, N. A. Kosheleva
"... conventionally managed. Kaplan-Meier curves revealed that risk of CHF decompensation (р=0.em001/em), mortality (р=0 ..."
 
Vol 3, No 5 (2007) EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
I. V. Vologdina
"... significantly in the 1st group in comparison with the 2nd group (29,5 % vs 11,5 %, p 0,em001/em). The exercise ..."
 
Vol 6, No 5 (2010) INTERRELATION BETWEEN PERSISTENT NECROSIS OF CARDIOMYOCYTES AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  PDF (Eng)  similar documents
E. N. Golovenko, D. A. Napalkov, V. A. Sulimov
"... (FC) III-IV than in those with CHF of FC I-II (p0.em001/em). Negative correlation was revealed between TrI ..."
 
Vol 10, No 5 (2014) CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE Abstract  similar documents
S. V. Gatsura, O. A. Gatsura, A. N. Golosova
"... displaced the leaders and increased their popularity from 11.3% in 2011-12 to 18.0% in 2013-14 (рem0.01/em ..."
 
Vol 4, No 3 (2008) COMBINED ANTIHYPERTENSIVE THERAPY IN METABOLIC SYNDROME Abstract  similar documents
E. I. Mananko, E. A. Bushkova, E. M. Idrisova, A. I. Vengerovsky
"... emкарведилолом/em 90 80 70 60 50 40 30 20 10 0 Общая длитель- ность эпизодов (мин) pem0,01/em pem0,01/em 80,6 0,9 31 ..."
 
Vol 4, No 1 (2008) VASCULAR REMODELING AND HEART RATE VARIABILITY IN DIFFERENT ANTIHYPERTENSIVE THERAPIES Abstract  similar documents
E. D. Golovanova
"... and emperindopril/em (Noliprel Forte, 1 tab/d: emperindopril/em 4 mg and indapamide 1,25 mg) on pulse wave velocity (PWV ..."
 
Vol 1, No 1 (2005) ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES Abstract  similar documents
Y. A. Karpov
"... in patients without left ventricle dysfunction are demonstrated in studies EUROPA with emperindopril/em 8 mg ..."
 
Vol 1, No 3 (2005) COMPARATIVE ASSESSMENT OF EFFECT OF COMBINED DRUGS OF ACE INHIBITOR AND DIURETIC (“NOLIPREL FORTE” AND “CAPOZIDE”) ON CARDIOVASCULAR REMODELING IN HYPERTENSIVE PATIENTS Abstract  similar documents
T. D. Kaplanov, V. V. Ivanenko, N. V. Ryasancevа, A. V. Legkiy, L. P. Anisimova, Yu. M. Lopatin
"... of combined drug of ACE inhibitors and diuretic. 25 patients took NF (emperindopril/em 4 mg and indapamide 1,25 mg ..."
 
Vol 7, No 6 (2011) COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES Abstract  similar documents
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk
"... in groups A, B or C. Patients of group A (n=25) received a fixed combination of the original emperindopril/em ..."
 
Vol 6, No 2 (2010) NEBIVOLOL – ESPECIAL BETA-ADRENOBLOCKER Abstract  similar documents
T. Műnzel, T. Gori
"... рынок США. Как и emкарведилол/em, небиволол относится к третьему поколению β-блокаторов, обладающих наряду с ..."
 
Vol 6, No 2 (2010) VALSARTAN IN EVERYDAY CLINICAL PRACTICE IN RUSSIA: ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik
"... patients (37,5/18,5 and 37,6/15,9 mm Hg respectively, рem0,01/em vs baseline). 312 patients (56,9% men, 43 ..."
 
Vol 4, No 2 (2008) MILDRONATE EFFECT ON ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH CHRONIC HEART FAILURE: DOUBLE BLIND CROSSOVER STUDY Abstract  similar documents
L. G. Voronkov, A. A. I.Shkurat, E. A. Lutsak
"... than this in control group (pem0,01/em) during RH test. After mildronate infusion increase in %∆D during RH ..."
 
Vol 10, No 2 (2014) THE FEATURES OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH METABOLIC SYNDROME Abstract  similar documents
L. V. Kremneva, O. V. Abaturova, S. V. Shalaev
"... -адреноблокаторы со свойствами вазодилата- торов (emкарведилол/em, небиволол) не оказывают отрица- тельного влияния на ..."
 
Vol 6, No 2 (2010) IN THE ISSUE Abstract  similar documents
"... % московских и 61% воронежских врачей. Оригинальные исследования Effects of emcarvedilol/em on platelet ..."
 
Vol 10, No 5 (2014) OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... significantly increased all-cause death risk (OR=2.49, р=0.008; OR=2.46, р=em0.01/em; OR=7.6, р=0.003; OR=15.3, р=em0.01/em ..."
 
Vol 6, No 1 (2010) ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY Abstract  similar documents
V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik
"... . SBP decreased by 37,5 mm Hg (рem0,01/em) in smoking patients and by 37,6 mm Hg (рem0,01/em) in non-smoking ..."
 
Vol 8, No 6 (2012) MODERN VIEWS ON THE VARIABILITY OF BLOOD PRESSURE Abstract  similar documents
V. M. Gorbunov
"... in patients of amlodipine/emperindopril/em treatment group was significantly lower than this in patients ..."
 
Vol 7, No 5 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva
"... decreased 2 hours after nebivolol intake both single one and after 30 days of treatment (p0.em001/em). Duration ..."
 
Vol 7, No 5 (2011): ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ ЛЕКАРСТВЕННОЙ ТЕРАПИИ ПРИ ПЕРВИЧНОЙ И ВТОРИЧНОЙ ПРОФИЛАКТИКЕ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ. РЕКОМЕНДАЦИИ ВНОК, 2011 Abstract  similar documents
, , , , , , , ,
"... - Candesartan in the Prevention of Relapsing Atrial Fibrillation CAPRICORN - emCarvedilol/em Post Infarct Survival ..."
 
Vol 3, No 1 (2007) THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION Abstract  similar documents
D. B. Nebieridze, A. S. Safaryan
"... of ACE inhibitors (ramipril, emperindopril/em), which are associated with vasoprotection. ..."
 
Vol 8, No 5 (2012) EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov
"... to moderate DM type 2 were included into the study. The patients were treated with emperindopril/em (5–10 mg/day ..."
 
Vol 6, No 6 (2010) THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina
"... , на- долол, emкарведилол/em и др.) действуют в одинаковой степени на оба типа бета-адренорецепторов, они на ..."
 
Vol 9, No 2 (2013) A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE Abstract  similar documents
G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi
"... ,744-0,927], р=0,em001/em), ИМ (ОШ:0,811 [95% ДИ 0,748-0,879], р0,em001/em), инсульта (ОШ: 0,796 [95% ДИ 0,682-0 ..."
 
Vol 8, No 4 (2012) INFLUENCE OF QUINAPRIL ON THE REGULATORY-ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE HYHA CLASS I: RESULTS OF NOT COMPARATIVE STUDY Abstract  similar documents
V. G. Tregubov, S. G. Kanorskiy, V. M. Pokrovskiy
"... .3%; pem0.01/em), as well as RAS index from 52.6±7.8 to 89.7±8.9 (Δ41.4%; pem0.01/em), and decrease ..."
 
Vol 6, No 3 (2010) WHAT DOES PROVIDE A CLINICAL EFFICACY OF METOPROLOL? Abstract  similar documents
E. V. Kuleshova
"... БАБ (метопролол, пропранолол, тимолол, ацебутолол, emкарведилол/em), для которых доказана способность до ..."
 
Vol 5, No 5 (2009) THE COMPARATIVE COST-EFFICACY ANALYSIS OF VARIOUS ANTIHYPERTENSIVE THERAPIES Abstract  similar documents
S. V. Malchikova, E. I. Tarlovskaya
"... indapamide retard plus emperindopril/em; group B - indapamide retard plus amlodipine; group C - amlodipine plus ..."
 
Vol 13, No 4 (2017) CLINICAL ADVANTAGES OF TELMISARTAN: FEATURES OF PHARMACOKINETICS, PHARMACODYNAMICS AND EFFECTS ON THE DAILY BLOOD PRESSURE PROFILE Abstract  similar documents
O. D. Ostroumova, E. A. Smolyarchuk, O. V. Bondarec, E. E. Paleeva
"... 33% – в группе без избыточного утреннего подъема АД (р0,em001/em). Частота инсульта за период наблюдения ..."
 
Vol 13, No 2 (2017) POSSIBILITIES OF IVABRADINE, A SELECTIVE INHIBITOR OF ION F-CHANNELS OF SINUS NODE, IN PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER Abstract  similar documents
Yu. V. Vasyuk, V. V. Nesvetov, E. L. Shkolnik, L. D. Shkolnik, G. V. Varlan, G. E. Gendlin, E. I. Emelina
"... in heart rate was observed already by the first month (from 83.6±9.5 to 67.1±7.5 beats/min, p0.em001/em ..."
 
Vol 8, No 4 (2012) RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS  similar documents
S. R. Willoughby, S. Rajendran, W. P. Chan, N. Procter, S. Leslie, E. A. Liberts, T. Heresztyn, Y. Y. Chirkov, J. D. Horowitz
"... тромбоцитов реагировать на NO по результатам оценки агрегации (р0,em001/em), но этот эффект наблюдался ..."
 
Vol 12, No 1 (2016) The main factors affecting the long-term outcomes in patients after acute cerebrovascular disorder: results of the LIS-2 study Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, A. V. Suvorov, A. V. Zagrebelnyy, M. L. Ginzburg, A. D. Deev
"... Демографические факторы Пожилой возраст 1,1 1,04 1,07 0,em001/em Мужской пол 0,8 0,60 1,32 0,088 Факторы риска сердечно ..."
 
Vol 13, No 2 (2017) SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
"... сравнению с 2006 г. Bisoprolol Бисопролол Metoprolol Метопролол emCarvedilol/em emКарведилол/em Nebivolol ..."
 
Vol 13, No 4 (2017) CLINICAL PRACTICE OF BETA-BLOCKERS USAGE IN PATIENTS WITH CARDIOVASCULAR AND CHRONIC RESPIRATORY DISEASES. DATA OF OUTPATIENT REGISTRIES PROFILE AND RECVASA Abstract  similar documents
S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, Yu. V. Lukina, M. M. Loukianov, A. N. Vorobyev, A. N. Kozminsky
"... were prescribed more often (51.1%) than in the RECVASA registry (31.5%, pem0.01/em), primarily to patients ..."
 
Vol 5, No 2 (2009) INNOVATIVE ANTIHYPERTENSIVE THERAPY IN THE LIGHT OF COMPLETED CLINICAL TRIALS Abstract  similar documents
N. A. Nikolaev
"... - полнительным вазодилатирующим действием (неби- волол и emкарведилол/em), а также бопиндолол, бетаксолол, бисопролол ..."
 
Vol 15, No 2 (2019) Pharmacoepidemiological Research of the Efficacy of Fixed Dose Combinations in the Treatment of Patients with Arterial Hypertension in Ambulatory Practice Abstract  similar documents
E. V. Yakukhnaya, E. V. Solyanik, V. V. Khitrina, Yu. V. Kuznetsova
"... dose combinations in Vladivostok polyclinics was performed. Two-component (emperindopril/em + amlodipine ..."
 
Vol 9, No 5 (2013) THE ROLE OF PARVOVIRUS B19 IN THE DEVELOPMENT OF INFLAMMATORY CARDIOMYOPATHY Abstract  similar documents
A. Yu. Shchedrina, A. A. Skvortsov, K. A. Zykov, A. A. Safiullina, S. N. Tereshchenko
"... кардиомиопатия (emДКМП/em) является ведущей причиной внезапной смерти у лиц младше 40 лет, и порядка 50% пациентов с ..."
 
Vol 5, No 3 (2009) IN THE ISSUE Abstract  similar documents
"... — антигипертензивная эффективность и безопасность emкарведилола/em при АГ и ожирении и/или диабете 2-го типа (с. 19) В ..."
 
Vol 12, No 4 (2016) Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva
"... 0,em001/em). Однако достоверное повышение рис- ка было выявлено только при применении пропраноло- ла и ..."
 
Vol 15, No 5 (2019) Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis Abstract  similar documents
L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok
"... group were older than these in the first group (p0.em001/em). Patients of the group 1 compared to the group ..."
 
Vol 6, No 2 (2010) CLINICAL APPROACHES TO INTERPRETATION OF CLINICAL TRAILS RESULTS ON BETA-BLOCKERS FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
S. R. Giljarevskiy, I. M. Kuzmina
"... Congestive Heart Failure, CIBIS II — Cardiac Insufficiency Bisoprolol Study и COPERNICUS — emCarvedilol/em ..."
 
Vol 12, No 5 (2016) Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine Abstract  similar documents
O. V. Zimnitskaya, M. M. Petrova
"... ,897 [144,662; 711,959] [56,386; 331,304]* [77,218; 259,104] [46,658; 272,537] *р0,05, **рem0,01/em, ***р0,em001/em ..."
 
Vol 6, No 6 (2010) COMBINATION THERAPY OF HYPERTENSION — A RELIABLE WAY TO TARGET ACHIEVE Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... высокую эффектив- ность комбинированной терапии дженерическими препаратами emкарведилола/em или метопролола ..."
 
Vol 2, No 2 (2006) THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL Abstract  similar documents
Y. R. Kasherininov, E. K. Shavarova, A. A. Shavarov, N. V. Vachrameeva, A. N. Krutikov, E. V. Smirnova, A. O. Коnrady, E. V. Shlyakhto
"... .8±0.6 to 5.2±0.7 mmol/l (pem0.01/em). The AUC of glucose in rilmenidine group decreased from 860±93 to 737 ..."
 
Vol 2, No 1 (2006) EFFECT OF ANTIHYPERTENSIVE THERAPY WITH RILMENIDINE ON COGNITIVE FUNCTION IN ELDERLY HYPERTENSIVE PATIENTS Abstract  similar documents
S. V. Nedogoda, U. A. Brel, T. A. Tchalyaby, E. S. Kesareva, V. A. Tcoma
"... of monotherapy with rilmenidine, decrease in daily average systolic blood pressure (SBP) by 7.2% (pem0.01/em ..."
 
Vol 9, No 1 (2013) FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Ya. Bart, E. A. Vartanyan
"... (p0.em001/em), they were more often diagnosed with left ventricular aneurysm (p=0.em001/em), chronic kidney ..."
 
1 - 100 of 813 Items 1 2 3 4 5 6 7 8 9 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)